Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05071976 · ClinicalTrials.gov registry record · NA
A Study of Near-Infrared Fluorescence Imaging With ICG During Reconstructive Gynecologic Surgery
A NA study of Gynecologic Surgery, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 7
- Study locations
NCT05071976: Active NA study of Gynecologic Surgery, sponsored by Memorial Sloan Kettering Cancer Center.
NCT05071976 is a NA study of Gynecologic Surgery that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05071976, a NA study of Gynecologic Surgery, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 7
- Study locations
Study Summary
The objective of this study is to assess whether Near-Infrared Fluorescence/NIR Imaging perfusion alters intraoperative management of the flap or of the participant wound bed.
Primary Outcome
The primary purpose of this study is to introduce ICG-NIR angiography in abdominopelvic skin and myocutaneous pedicle flap-based reconstruction during gynecologic oncology surgery and determine the percentage of cases in which intraoperative ICG-NIR angiography altered surgical flap reconstruction plans.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST ICG-NIR angiography
Study Locations (7)
New York
- Memorial Sloan Kettering Suffolk - Commack (Consent and Followup) - Commack
- Memorial Sloan Kettering Westchester (Consent and Followup) - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (Consent and Followup) - Rockville Centre
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent and Followup) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent and Followup) - Middletown
- Memorial Sloan Kettering Bergen (Consent and Followup) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-09-24 |
| Est. Completion | 2026-10-24 |
| Phase | NA |
What the registry record for NCT05071976 still lists
NCT05071976 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Gynecologic Surgery appearing as the primary indexed condition, and to 1 intervention - of which ICG-NIR angiography is the first listed.
NCT05071976 lists 7 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT05071976 about?
NCT05071976 is a clinical study titled "A Study of Near-Infrared Fluorescence Imaging With ICG During Reconstructive Gynecologic Surgery". The objective of this study is to assess whether Near-Infrared Fluorescence/NIR Imaging perfusion alters intraoperative management of the flap or of the participant wound bed.
What is the current status of trial NCT05071976?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2021-09-24. Estimated completion is 2026-10-24.
What conditions does trial NCT05071976 study?
This clinical trial studies the following conditions: Gynecologic Surgery.
What interventions are being tested in trial NCT05071976?
The interventions under investigation include: ICG-NIR angiography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05071976?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05071976 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05071976's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI